Company Profiles

driven by the PitchBook Platform

Respicardia

Description

Developer of implantable stimulation device to improve cardiovascular health. The company develops implantable therapies designed to improve respiratory rhythm management and cardiovascular health in an attempt to restore natural breathing during sleep for patients with central sleep apnea.

2006

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$25.1M

Latest Deal Amount

$100M

Total Amount Raised

Description

Developer of implantable stimulation device to improve cardiovascular health. The company develops implantable therapies designed to improve respiratory rhythm management and cardiovascular health in an attempt to restore natural breathing during sleep for patients with central sleep apnea.

Website:

www.respicardia.com

Formerly Known As

Cardiac Concepts

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Devices and Supplies

Primary Office

12400 Whitewater Drive Suite 150 Hopkins, MN 55343United States +1 (952) 540-4470
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Respicardia's full profile, request a free trial.

Respicardia Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Respicardia Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Respicardia Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Abbott VenturesCorporate Venture CapitalMinority000 0000000 0000
Accuitive Medical VenturesVenture CapitalMinority000 0000000 0000
Affinity Capital ManagementVenture CapitalMinority000 0000000 0000
Ares CapitalVenture CapitalMinority000 0000000 0000
Polaris PartnersVenture CapitalMinority000 0000000 0000
Abbott Ventures Corporate Venture Capital
Accuitive Medical Ventures Venture Capital
Affinity Capital Management Venture Capital
Ares Capital Venture Capital
Polaris Partners Venture Capital

Respicardia Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Bonnie LaboskyChief Executive Officer, Board Member & President
Timothy HauchChief Financial Officer
Frank Piskolich JDGeneral and IP Counsel
Linda NelsonVice President, Clinical Affairs
Todd GoblishVice President, Research & Development
Bonnie Labosky Chief Executive Officer, Board Member & President
Timothy Hauch Chief Financial Officer
Frank Piskolich JD General and IP Counsel
Linda Nelson Vice President, Clinical Affairs
Todd Goblish Vice President, Research & Development

Respicardia Board Members (8)

NameRepresentingRoleSinceContact
Info
Edward AndrleSorinVice President, Strategy & Business Development000 0000
Kevin WassersteinVersant VenturesAffiliated Director000 0000
Kirk NielsenVersant VenturesManaging Director000 0000
Kristine JohnsonAffinity Capital ManagementPresident000 0000
Scott WardSelfBoard Member000 0000
Edward Andrle Vice President, Strategy & Business Development Sorin
Kevin Wasserstein Affiliated Director Versant Ventures
Kirk Nielsen Managing Director Versant Ventures
Kristine Johnson President Affinity Capital Management
Scott Ward Board Member Self
Request full access to PitchBook